Norketamine: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
'''Norketamine''' is a [[metabolite]] of the [[anesthetic]] drug [[ketamine]]. It is formed in the body | {{DISPLAYTITLE:Norketamine}} | ||
== Norketamine == | |||
[[File:Norketamine.svg|thumb|right|Chemical structure of Norketamine]] | |||
'''Norketamine''' is a [[metabolite]] of the [[anesthetic]] and [[analgesic]] drug [[ketamine]]. It is formed in the body through the process of [[N-demethylation]] by the [[cytochrome P450]] enzyme system, primarily in the [[liver]]. Norketamine retains some of the pharmacological properties of ketamine, contributing to its overall effects. | |||
== Pharmacology == | == Pharmacology == | ||
Norketamine acts on the [[central nervous system]] and has been shown to interact with the [[N-methyl-D-aspartate receptor|NMDA receptor]], similar to its parent compound, ketamine. However, it has a lower affinity for the NMDA receptor compared to ketamine. This interaction is believed to contribute to its [[analgesic]] and [[dissociative]] effects. | |||
=== Metabolism === | |||
The metabolism of ketamine to norketamine occurs primarily in the liver. The enzyme [[CYP3A4]] is mainly responsible for the N-demethylation of ketamine to norketamine. Once formed, norketamine can undergo further metabolism to produce other metabolites, such as [[dehydronorketamine]]. | |||
== | == Clinical Significance == | ||
Norketamine is considered to have a role in the therapeutic effects of ketamine, particularly in its use as an [[antidepressant]]. The presence of norketamine in the body may prolong the effects of ketamine, contributing to its [[antidepressant]] and [[analgesic]] properties. | |||
== Research == | |||
Research into norketamine has focused on its potential therapeutic effects and its role in the overall pharmacological profile of ketamine. Studies have investigated its effects on [[pain management]] and its potential use in treating [[depression]]. | |||
== | |||
== Related pages == | |||
* [[Ketamine]] | * [[Ketamine]] | ||
* [[ | * [[NMDA receptor]] | ||
* [[ | * [[Analgesic]] | ||
* [[ | * [[Antidepressant]] | ||
[[Category:Anesthetics]] | [[Category:Anesthetics]] | ||
[[Category: | [[Category:Analgesics]] | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
Latest revision as of 03:55, 13 February 2025
Norketamine[edit]
Norketamine is a metabolite of the anesthetic and analgesic drug ketamine. It is formed in the body through the process of N-demethylation by the cytochrome P450 enzyme system, primarily in the liver. Norketamine retains some of the pharmacological properties of ketamine, contributing to its overall effects.
Pharmacology[edit]
Norketamine acts on the central nervous system and has been shown to interact with the NMDA receptor, similar to its parent compound, ketamine. However, it has a lower affinity for the NMDA receptor compared to ketamine. This interaction is believed to contribute to its analgesic and dissociative effects.
Metabolism[edit]
The metabolism of ketamine to norketamine occurs primarily in the liver. The enzyme CYP3A4 is mainly responsible for the N-demethylation of ketamine to norketamine. Once formed, norketamine can undergo further metabolism to produce other metabolites, such as dehydronorketamine.
Clinical Significance[edit]
Norketamine is considered to have a role in the therapeutic effects of ketamine, particularly in its use as an antidepressant. The presence of norketamine in the body may prolong the effects of ketamine, contributing to its antidepressant and analgesic properties.
Research[edit]
Research into norketamine has focused on its potential therapeutic effects and its role in the overall pharmacological profile of ketamine. Studies have investigated its effects on pain management and its potential use in treating depression.
